Brain Res Bull, 2011 · DOI: 10.1016/j.brainresbull.2010.05.013 · Published: March 10, 2011
After spinal cord injury, it's hard to get axons to grow or regenerate because the environment isn't supportive and neurons don't have much ability to grow on their own. Neurotrophins can help sensory axons regenerate after certain injuries, but they don't always go to the right place. To help axons grow in the right direction, scientists have tried building pathways using a combination of treatments. These treatments aim to increase the growth potential of neurons, create a bridge across the injury site, and provide a supportive surface for axons to grow out of the bridge and back into the surrounding tissue. In cases where nerve circuits are lost, pre-made supportive pathways can help transplanted neurons grow axons over long distances to reach their targets.
Combined therapies that address multiple aspects of axon regeneration, such as intrinsic growth ability, lesion bridging, and growth substrate provision, hold promise for spinal cord injury treatment.
Findings from animal models need careful consideration for translation to human clinical trials, particularly regarding cell type selection, delivery methods, and post-surgical assessments.
Creating controlled neurotrophin gradients can enhance axon outgrowth and targeting, but careful attention must be paid to avoid inappropriate targeting due to overexpression or incorrect placement.